THE BLOG

SunWaves-MedTech sets up in Nice to develop the connected medicine of tomorrow

sunwaves medtech nice — *^{Philippe Dedrie, CEO and co-founder (c) All rights reserved}*

Founded by three experts from medicine, law, and the pharmaceutical industry, the medtech company SunWaves-MedTech is establishing its headquarters in Nice and its R&D center in Sophia-Antipolis to develop a connected, preventive, and accessible form of medicine in support of physicians.

Thanks to its proprietary artificial intelligence platform and a 24/7 Medical Supervision Center, SunWaves offers global, proactive, and personalized monitoring that combines AI and human expertise to enhance the safety and continuity of care.

In response to a stark reality—23 million French citizens live in medical deserts, and 9 million lack a primary care physician—SunWaves is building a technological and human medical monitoring system without any disruption in the care pathway.

Supported by the Nice Côte d’Azur ecosystem and the assistance of Team Nice Côte d’Azur for its establishment, the company is embedding itself in a region that is both innovative, collaborative, and globally connected.

Interview with Philippe Dedrie, CEO and co-founder (pictured).

You are three co-founders. What brought you together around SunWaves-MedTech?

It all started with a long-standing friendship and a shared belief: the medicine of tomorrow must be more continuous, more preventive, and more accessible.

With Alexandre, a Professor of Medicine, and Laurent, a lawyer specializing in disruptive structures, we wanted to combine our expertise to build a health model centered on the person, not the pathology.

Initially, we wanted to improve the daily lives of elderly people, often facing medical isolation and discontinuity of care. But we quickly realized the scope of a much larger issue. In France, 23 million people live in medical deserts, 9 million have no general practitioner, and nearly 500,000 patients with long-term illnesses are not regularly monitored.

These figures reveal that a growing part of the population no longer has access to structured and responsive medical support. We wanted to respond to this major need by creating a proactive medical safety net—useful to patients, doctors, caregivers, and healthcare professionals alike.

How do you plan to address this growing need for medical support?

SunWaves-MedTech offers a global, responsive, continuous, and personalized medical monitoring service operating 24 hours a day, 7 days a week, without effort for the patient.

Our technology captures up to 70 physiological and behavioral parameters in real time from connected devices—watches, medical sensors, under-mattress monitors, glucometers, among others. The system is interoperable, discreet, and naturally integrates into everyone’s daily life.

These data are then analyzed by our proprietary medical AI, designed by physicians. It doesn’t just flag anomalies: it cross-references data, identifies weak signals, anticipates risks (decompensation, falls, silent deterioration, etc.), and personalizes alert thresholds based on individual profiles, living contexts, and treatments. It follows a rigorous chain: data integration, analysis, risk scoring, then coordinated activation of appropriate medical actions. This predictive engine turns information into useful action at the right moment.

Each alert is then validated by our medical team, available at all times. The response may range from a verification call to a teleconsultation, or even referral to emergency services. The attending physician is integrated into the process—with the patient’s consent. They remain informed, involved, and retain full authority in medical decision-making.

We do not conduct consultations, practice medicine, or issue prescriptions. What we offer is a caring, responsive medical watch. A form of medicine that anticipates, accompanies, and reestablishes a direct, fluid, and structured link between patients, caregivers, and healthcare professionals.

In all cases, our role is not to replace physicians or prescribe treatment, but to ensure continuous medical presence and intelligent triage, 24/7. SunWaves’ medical AI analyzes data, detects weak signals, and prioritizes alerts; the Medical Supervision Center (MSC), composed of healthcare professionals, validates and directs each situation according to protocols established with partner doctors.

Thus, we never act in place of the doctor; we provide objective, contextualized, and concise information that enables them to focus their expertise on the cases that truly require it.

What sets you apart from other telemonitoring or connected device solutions?

We don’t just collect data: we understand it, qualify it, and act upon it.

Our AI cross-checks data, eliminates false positives, and detects weak signals. Most importantly, it never replaces humans. It strengthens medical reasoning—it does not automate the care relationship.

That’s what makes our approach credible and relevant: it’s designed by doctors, for doctors, and for real patients—with their history, daily life, and concerns.

While other solutions tend to impose a surveillance mindset, we focus on accompaniment and respect for the individual, within a framework that strictly complies with GDPR and medical data protection. We are there when people need us.

You chose to establish yourselves on the Nice Côte d’Azur. Why?

We were first contacted in 2024 by Université Côte d’Azur as part of the Ulysseus European University project. At that time, we didn’t know the region at all. But from our very first visit to Nice, everything fell into place.

We found an exceptional ecosystem, with a strong dynamic around e-health, applied research, and artificial intelligence. And above all, a capacity for immediate action. We weren’t told, “Let’s meet in three months.” We were received, listened to, and connected quickly and effectively.

The region also offers a strategic international gateway, with Nice Côte d’Azur Airport—the second largest hub in France after Paris—facilitating connections to Europe, North America, and the Mediterranean Basin. It’s a tangible advantage for our teams, partners, and international expansion projects.

Today, our headquarters are based in Nice, and our R&D center is in Sophia Antipolis.

Our entire French and international strategy is managed from Nice Côte d’Azur.

What role did Team Nice Côte d’Azur play?

Team Nice Côte d’Azur played a decisive role. Hervé Laubertie and Sana Bouyahia immediately grasped our vision. They facilitated connections with the Nice Côte d’Azur Metropolis, healthcare stakeholders, sports networks, and medico-social structures. They built an operational ecosystem around us.

We also received support from RisingSud, the Région Sud, and Université Côte d’Azur, which integrated us into concrete research projects in collaboration with leading laboratories such as École des Mines Paris.

What we found here is a territory that acts coherently, where institutions don’t just support—they cooperate.

Which markets are you targeting today?

In 2025, we are launching three ready-to-market verticals:

SunWaves-Autonomy, for elderly people, those with chronic diseases, and people with disabilities,
SunWaves-Open IoT, for users of consumer-connected devices,
SunWaves-Sport, for clubs, federations, elite athletes, and amateurs.

Five more verticals are under development for 2026–2027: post-hospitalization, oncology, healthcare in remote areas, clinical trials, and longevity. Our technology is designed as a modular architecture adaptable to every use case.

We are also ready to expand internationally. The platform is already multilingual and interoperable. We’ve received inquiries from Germany, Canada, and several European countries. For now, our priority remains steady growth in France.

Our international expansion will follow the same standard of quality and local integration as our French launch.

What are the specific features of your organization?

We wanted to build a human-scale, agile, yet demanding company.

We made bold choices:

Flexible remote work,
Chosen working time,
No rigid hierarchy,
And a paperless company.

We also launched an innovative program: SunMakers, enabling retirees or early retirees to become ambassadors of our solution in their neighborhoods. They are best positioned to create social bonds, talk to their neighbors, and spread awareness of our offer in a spirit of trust. It’s an economic project, but also a deeply human adventure with a strong local impact.

What are the next steps?

We will have around twenty employees by the end of 2025, and about seventy-five by the end of 2026. Recruitment focuses on AI, data science, medical supervision, and patient relations. Being based in Nice is a strong factor for attracting and retaining both national and international talent.

We also plan to relocate our Paris-based autonomy division to Nice in 2026, to centralize all our activities in the region. We are preparing thematic spin-offs, particularly in sports, oncology, and clinical trials, which will remain locally anchored.

Finally, we are strengthening collaborations with laboratories, universities, and field actors to continue innovating seriously and ambitiously.

Any final words?

We came to the Côte d’Azur without really knowing it. We are staying today out of conviction. It is a place where life is good—and above all, where it is good to build. The conditions here are both structured, demanding, and caring.

We are carrying a meaningful project. And here, everything is in place for it to grow under the best possible conditions.

Contact information:
Philippe Dedrie – CEO
📧 pdedrie@sunwaves-medtech.com
📞 +33 7 56 88 38 08